Nasal Cannula Market Forecast 2025-2034: Comprehensive Insights On Market Size, Growth, Trends, Competitive Landscape

February 27, 2025 03:58 AM GMT | By EIN Presswire
 Nasal Cannula Market Forecast 2025-2034: Comprehensive Insights On Market Size, Growth, Trends, Competitive Landscape
Image source: EIN Presswire

LONDON, GREATER LONDON, UNITED KINGDOM, February 27, 2025 /EINPresswire.com/ -- The Global Nasal Cannula Market Has Seen Noteworthy Growth In Recent Years, So What's Driving This Positive Trend?

The nasal cannula market size, boosted by increases in personalized patient care, a rise in obstructive sleep apnea incidences, and growing awareness of respiratory diseases, grew from $8.93 billion in 2024 to an expected $9.82 billion in 2025, at a compound annual growth rate CAGR of 9.9%.

Looking ahead, the market is expected to continue its strong growth in the next few years. It is projected to reach $14.17 billion by 2029, at a CAGR of 9.6%. This predicted growth can be attributed to the increasing prevalence of respiratory diseases, increasing healthcare expenditure, a growing geriatric population, increasing government initiatives, and an increasing number of surgeries.

Get Your Free Sample Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20895&type=smp

What Drives The Nasal Cannula Market Growth?

The rise of respiratory diseases is a significant factor contributing to the growth of the nasal cannula market. Respiratory diseases, which affect the lungs and airways and impair breathing and oxygen exchange, are driven by factors such as air pollution, smoking, viral infections, and increased exposure to allergens. The nasal cannula, used in respiratory diseases, delivers supplemental oxygen directly into the nostrils, improving oxygen levels for those with breathing difficulties.

Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/nasal-cannula-global-market-report

Who Are The Key Players In The Nasal Cannula Market?

Key industry players play a significant role in the growth of the nasal cannula market. Notably, Cardinal Health Inc., Medline Industries Inc., Becton Dickinson and Company, ResMed Inc., Teleflex Incorporated, Angiplast Pvt. Ltd., Fisher & Paykel Healthcare Limited, Drive DeVilbiss Healthcare LLC, Well Lead Medical Co. Ltd., GaleMed Corp., Vapotherm Inc., Salter Labs Inc., Dynarex Corporation, Mais India Medical Devices Pvt. Ltd., Allied Medical LLC, Besmed Health Business Corp., Flexicare Medical Ltd., Medin Medical Innovations AB, Airways Surgical Pvt. Ltd., Great Group Medical Co. Ltd., and HUM GmbH all have significant impact.

What Are The Emerging Trends In The Nasal Cannula Market?

An emerging trend worth noting is the focus of industry-leading companies on technological innovations. For instance, innovations such as low-flow nasal cannulas, which are designed to provide supplemental oxygen at lower flow rates and improve overall comfort and oxygen delivery efficiency, are being increasingly adopted in the market.

How Is The Nasal Cannula Market Segmented?

The nasal cannula market report further breaks down the market into segments and subsegments. It is segmented by type into Low-Flow Nasal Cannula and High Flow Nasal Cannula, by material into Plastic and Silicone, and by size into Neonate, Infant, Child, and Adult. Further, it is segmented by prongs into Straight, Curved, Flared, and Other Prongs, and by end user into Hospitals, Ambulatory Healthcare Services, Long Term Care Centers, and Other End Users.

What Is The Regional Analysis Of Nasal Cannula Market?

Regional insights indicate North America held the largest share of the nasal cannula market in 2024. The report further covers other regions including Asia-Pacific, Western Europe, Eastern Europe, South America, the Middle East, and Africa.

Browse For More Similar Reports-

Nasal Polyps Treatment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/nasal-polyps-treatment-global-market-report
Inhalation And Nasal Spray Generic Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/inhalation-and-nasal-spray-generic-drugs-global-market-report
Nasal Drug Delivery Technology Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/nasal-drug-delivery-technology-global-market-report

About The Business Research Company:

The Business Research Company boasts a repository of over 15000+ reports spanning 27 industries and 60+ geographies. It prides itself on comprehensive, data-rich research and insights. Armed with 1.5 million datasets, in-depth secondary research, and unique insights from industry leaders, it provides valuable data that helps you to stay ahead in the game.

Get in touch:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us: [email protected]

Stay connected:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
Facebook
X
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalized advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


Sponsored Articles


Investing Ideas

Previous Next